Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

SHE:300534 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	274.85	289.65	288.95	369.24	99.12	118.19
Cash & Short-Term Investments	274.85	289.65	288.95	369.24	99.12	118.19
Cash Growth	-16.04%	0.24%	-21.75%	272.52%	-16.13%	128.90%
Accounts Receivable	225.14	216.67	223.8	220.95	140.44	164.56
Other Receivables	23.1	19.28	19.5	19.7	5.53	5.18
Receivables	248.24	235.95	243.3	240.65	145.98	169.73
Inventory	132.93	115.82	97.4	85.87	55.7	41.55
Prepaid Expenses	-	0.03	0.16	0.2	1.4	0.11
Other Current Assets	48	35.05	17.19	31.57	6.51	3.52
Total Current Assets	704.01	676.5	647	727.54	308.7	333.1
Property, Plant & Equipment	514.78	514.24	439.42	333.85	305.21	326.76
Long-Term Investments	51.36	51.36	54.2	54.2	54.2	54.2
Goodwill	13.72	13.72	13.72	13.72	13.72	18.51
Other Intangible Assets	62.53	62.81	62.07	62.22	50.74	52.01
Long-Term Deferred Tax Assets	11.5	11.5	10.12	8.58	5.77	6.01
Long-Term Deferred Charges	1.5	1.66	0.23	0.14	-	-
Other Long-Term Assets	74.14	70.51	109.89	117.25	85.73	76.07
Total Assets	1,434	1,402	1,337	1,318	824.07	866.66
Accounts Payable	367.77	361.08	243.56	209.01	32.63	6.53
Accrued Expenses	10.05	27.08	23.11	58.51	6.3	5.32
Short-Term Debt	1.22	-	30.03	-	-	70.07
Current Portion of Long-Term Debt	-	10.2	-	-	-	-
Current Portion of Leases	-	1.16	1.19	-	-	-
Current Income Taxes Payable	21.34	30.91	21.1	17.48	1.78	2.55
Current Unearned Revenue	6.94	22.4	65.65	77.24	12.96	3.9
Other Current Liabilities	84.92	66.52	53.7	45.08	14.64	15.12
Total Current Liabilities	492.24	519.35	438.34	407.32	68.32	103.48
Long-Term Debt	97.21	95.84	109.6	-	-	-
Long-Term Leases	2.43	2.58	3.72	-	-	-
Long-Term Unearned Revenue	49.47	31.33	26.44	26.89	22.92	24.04
Long-Term Deferred Tax Liabilities	1.54	1.54	0.24	-	0	0
Other Long-Term Liabilities	23.75	23.75	46.8	-	-	-
Total Liabilities	666.65	674.39	625.14	434.21	91.24	127.53
Common Stock	303.35	303.35	303.35	303.35	303.35	303.35
Additional Paid-In Capital	97.15	83.83	66.68	324	231.49	231.49
Retained Earnings	301.56	277.35	263.68	202.03	185.42	194.52
Comprehensive Income & Other	-2.24	-2.24	-	-	-	-
Total Common Equity	699.82	662.28	633.71	829.38	720.25	729.36
Minority Interest	67.07	65.64	77.8	53.92	12.59	9.78
Shareholders' Equity	766.89	727.93	711.51	883.3	732.84	739.13
Total Liabilities & Equity	1,434	1,402	1,337	1,318	824.07	866.66
Total Debt	100.86	109.78	144.54	-	-	70.07
Net Cash (Debt)	173.99	179.88	144.4	369.24	99.12	48.12
Net Cash Growth	-17.08%	24.56%	-60.89%	272.52%	105.97%	90.27%
Net Cash Per Share	0.57	0.59	0.48	1.22	0.33	0.16
Filing Date Shares Outstanding	303.35	303.35	303.35	303.35	303.35	303.35
Total Common Shares Outstanding	303.35	303.35	303.35	303.35	303.35	303.35
Working Capital	211.77	157.15	208.65	320.22	240.38	229.62
Book Value Per Share	2.31	2.18	2.09	2.73	2.37	2.40
Tangible Book Value	623.57	585.75	557.91	753.43	655.78	658.84
Tangible Book Value Per Share	2.06	1.93	1.84	2.48	2.16	2.17
Buildings	-	483.38	339.21	338.42	283.91	294.39
Machinery	-	198.76	148.61	125.14	66.35	65.82
Construction In Progress	-	27.61	105.7	6.09	37.76	35.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.